Avanos Medical, Inc.
AVNSFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Avanos Medical, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 14 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 12, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| NORTH STAR ASSET MANAGEMENT INC | 2026-03-31 | 20,543 | $288K | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 827,662 | $11.6M | SEC filing |
| N.E.W. Advisory Services LLC | 2026-03-31 | 97 | $1.36K | SEC filing |
| MARTINGALE ASSET MANAGEMENT L P | 2026-03-31 | 180,360 | $2.53M | SEC filing |
| Swiss National Bank | 2026-03-31 | 91,500 | $1.28M | SEC filing |
| Keating Financial Advisory Services, Inc. | 2026-03-31 | 37 | $518 | SEC filing |
| Kozak & Associates, Inc. | 2026-03-31 | 4 | $58 | SEC filing |
| INTECH INVESTMENT MANAGEMENT LLC | 2026-03-31 | 123,154 | $1.73M | SEC filing |
| Steward Partners Investment Advisory, LLC | 2026-03-31 | 12 | $168 | SEC filing |
| Engineers Gate Manager LP | 2026-03-31 | 63,873 | $895K | SEC filing |
| Bangor Savings Bank | 2026-03-31 | 31 | $434 | SEC filing |
| Arax Advisory Partners | 2026-03-31 | 990 | $13.9K | SEC filing |
| Sterling Capital Management LLC | 2026-03-31 | 20,938 | $293K | SEC filing |
| Cerity Partners LLC | 2026-03-31 | 24,305 | $341K | SEC filing |
| IAG Wealth Partners, LLC | 2026-03-31 | 2 | $28 | SEC filing |
| DEUTSCHE BANK AG\ | 2026-03-31 | 84,968 | $1.19M | SEC filing |
| Qube Research & Technologies Ltd | 2026-03-31 | 129,593 | $1.82M | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 20,039 | $281K | SEC filing |
| US BANCORP \DE\ | 2026-03-31 | 2,117 | $29.7K | SEC filing |
| Atlantic Edge Private Wealth Management, LLC | 2026-03-31 | 299 | $4.19K | SEC filing |
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Avanos Medical, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-11-18 · Holbrook Kerr: Larger than all 10 other insider sales of Common Stock on file. SEC filing
- 2025-08-13 · BLACKFORD GARY: Larger than all 9 other insider purchases of Common Stock on file. SEC filing
- 2025-03-06 · Holbrook Kerr: Larger than 9 of the 10 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-18 | Holbrook Kerr · SVP, Chief Commercial Officer | Common Stock | S — Open market or private sale | −100 | 11.01 | SEC filing |
| 2025-11-18 | Holbrook Kerr · SVP, Chief Commercial Officer | Common Stock | S — Open market or private sale | −305 | 11.02 | SEC filing |
| 2025-11-18 | Holbrook Kerr · SVP, Chief Commercial Officer | Common Stock | S — Open market or private sale | −761 | 11.01 | SEC filing |
| 2025-11-18 | Holbrook Kerr · SVP, Chief Commercial Officer | Common Stock | S — Open market or private sale | −13,834 | 11.00 | SEC filing |
| 2025-08-13 | BLACKFORD GARY · Director | Common Stock | P — Open market or private purchase | +40,000 | 11.00 | SEC filing |
| 2025-08-13 | BLACKFORD GARY · Director | Common Stock | P — Open market or private purchase | +20,000 | 10.98 | SEC filing |
| 2025-03-06 | Holbrook Kerr · SVP, Chief Commercial Officer | Common Stock | S — Open market or private sale | −7,000 | 15.25 | SEC filing |
| 2024-03-14 | Greiner Michael · SVP - Chief Financial Officer | Common Stock | S — Open market or private sale | −3,800 | 19.11 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-08 | Franchini Indrani Lall · Director | Restricted Share Units | A — Grant, award, or other acquisition | +12,003 | SEC filing |
| 2026-05-08 | Egbuonu-Davis Lisa · Director | Restricted Share Units | A — Grant, award, or other acquisition | +12,003 | SEC filing |
| 2026-05-08 | Shimer Julie Ann · Director | Restricted Share Units | A — Grant, award, or other acquisition | +12,003 | SEC filing |
| 2026-05-08 | BLACKFORD GARY · Director | Restricted Share Units | A — Grant, award, or other acquisition | +12,003 | SEC filing |
| 2026-05-08 | OLEARY PATRICK J · Director | Restricted Share Units | A — Grant, award, or other acquisition | +12,003 | SEC filing |
| 2026-04-22 | Galovan Scott Michael · SVP, Chief Financial Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −4,228 | SEC filing |
| 2026-04-22 | Delgado Sigfrido · SVP, Operations | Common Stock | F — Payment of exercise price or tax by delivering securities | −4,264 | SEC filing |
| 2026-04-14 | Pacitti David · Chief Executive Officer | Common Stock | F — Payment of exercise price or tax by delivering securities | −21,194 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.